{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:33:47Z","timestamp":1759530827302},"reference-count":19,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1016\/j.ejps.2004.01.008","type":"journal-article","created":{"date-parts":[[2004,3,6]],"date-time":"2004-03-06T10:39:45Z","timestamp":1078569585000},"page":"671-678","source":"Crossref","is-referenced-by-count":13,"title":["Gamma scintigraphic evaluation of the fate of hydroxypropyl methylcellulose capsules in the human gastrointestinal tract"],"prefix":"10.1016","volume":"21","author":[{"given":"Outi","family":"Honkanen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janne","family":"Marvola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna","family":"Kanerva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Lindevall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maija","family":"Lipponen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommi","family":"Kekki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aapo","family":"Ahonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martti","family":"Marvola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2004.01.008_BIB1","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0168-3659(93)90040-C","article-title":"Colonic transit of different sized tablets in healthy subjects","volume":"23","author":"Adkin","year":"1993","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.ejps.2004.01.008_BIB2","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1177\/106002808702100311","article-title":"Factors influencing the transit of a gelatin capsule in the esophagus","volume":"21","author":"Bailey","year":"1987","journal-title":"Drug Intell. Clin. Pharm."},{"key":"10.1016\/j.ejps.2004.01.008_BIB3","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1365-2125.1984.tb02464.x","article-title":"Antipyrine absorption after delayed oesophageal capsule transit","volume":"18","author":"Channer","year":"1984","journal-title":"Br. J. Clin. Pharmac."},{"key":"10.1016\/j.ejps.2004.01.008_BIB4","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1136\/gut.27.8.886","article-title":"Transit of pharmaceutical dosage forms through the small intestine","volume":"27","author":"Davis","year":"1986","journal-title":"Gut"},{"key":"10.1016\/j.ejps.2004.01.008_BIB5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0168-3659(90)90182-S","article-title":"GI transit of potential bioadhesive formulations in man: a scintigraphic study","volume":"12","author":"Harris","year":"1990","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.ejps.2004.01.008_BIB6","first-page":"181","article-title":"Bioavailability of ibuprofen from orally and rectally administered hydroxypropyl methyl cellulose capsules compared to corresponding gelatine capsules","volume":"11","author":"Honkanen","year":"2001","journal-title":"STP Pharma Sci."},{"key":"10.1016\/j.ejps.2004.01.008_BIB7","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0928-0987(02)00032-5","article-title":"Bioavailability and in vitro oesophageal sticking tendency of hydroxypropyl methylcellulose capsule formulations and corresponding hard gelatine capsule formulations","volume":"15","author":"Honkanen","year":"2002","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2004.01.008_BIB8","first-page":"299","article-title":"Bioavailability of metoclopramide from orally and rectally administered novel hydroxypropyl methylcellulose capsules containing different diluents: a comparison with corresponding gelatine capsules","volume":"12","author":"Honkanen","year":"2002","journal-title":"STP Pharma Sci."},{"key":"10.1016\/j.ejps.2004.01.008_BIB9","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/jps.2600710904","article-title":"Development of a method for study of the tendency of drug products to adhere to the esophagus","volume":"71","author":"Marvola","year":"1982","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2004.01.008_BIB10","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0378-5173(01)00696-2","article-title":"The in-vitro porcine adhesion model is not predictive of the esophageal transit of risedronate tablets in humans","volume":"222","author":"McCargar","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2004.01.008_BIB11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0928-0987(02)00224-5","article-title":"New developments in radionuclide imaging for assessing drug delivery in man","volume":"18","author":"Newman","year":"2003","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2004.01.008_BIB12","first-page":"32","article-title":"HPMC capsules\u2014an alternative to gelatin","volume":"11","author":"Ogura","year":"1998","journal-title":"Pharm. Tech. Eur."},{"key":"10.1016\/j.ejps.2004.01.008_BIB13","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.2042-7158.1988.tb05273.x","article-title":"The effect of capsule size and density on transit through the proximal colon","volume":"40","author":"Parker","year":"1988","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejps.2004.01.008_BIB14","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/gut.35.10.1363","article-title":"Impaired oesophageal transit of capsule versus tablet formulation in the elderly","volume":"35","author":"Perkins","year":"1994","journal-title":"Gut"},{"key":"10.1016\/j.ejps.2004.01.008_BIB15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0378-5173(99)00172-6","article-title":"Esophageal transit of risedronate cellulose-coated tablet and gelatin capsule formulations","volume":"186","author":"Perkins","year":"1999","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2004.01.008_BIB16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0939-6411(97)00100-8","article-title":"An in vitro-in vivo investigation of oral bioadhesive controlled release furosemide formulations","volume":"44","author":"Santus","year":"1997","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2004.01.008_BIB17","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0939-6411(03)00098-5","article-title":"Scintigraphic verification of adherence of a chitosan formulation to the human oesophagus","volume":"57","author":"S\u00e4kkinen","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2004.01.008_BIB18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0378-5173(89)90140-3","article-title":"Bimodal release of ibuprofen in a sustained-release formulation: a scintigraphic and pharmacokinetic open study in healthy volunteers under different conditions of food intake","volume":"50","author":"Wilson","year":"1989","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2004.01.008_BIB19","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0378-5173(88)90084-1","article-title":"A gamma scintigraphic study to compare oesophageal clearance of \u201cExpidet\u201d formulations, tablets and capsules in supine volunteers","volume":"46","author":"Wilson","year":"1988","journal-title":"Int. J. Pharm."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098704000259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098704000259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T20:28:23Z","timestamp":1550176103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098704000259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["S0928098704000259"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2004.01.008","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]}}}